Industry Research Reports
Home > Reports > Service & Software > Global AI-enabled Imaging Modality Market Outlook, In‑Depth Analysis & Forecast to 2031
Global AI-enabled Imaging Modality Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-10-23
Pages: 123 Pages
Report ld: 5220583
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global AI-enabled Imaging Modality market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global AI-enabled Imaging Modality market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Koninklijke Philips N.V.
- Siemens Healthineers AG.
- General Electric Company
- Canon
- Hologic
- Butterfly Network
- Hyperfine
- United Health Imaging
- Yorlabs
- Nanox
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Computed Tomography
- MRI
- X-Ray
- Ultrasound
- Positron Emission Tomography
- Others
Segment by Application
- Hospital
- Cilinic
- Labs
CHAPTER OUTLINE
Chapter 1: Defines the AI-enabled Imaging Modality study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to AI-enabled Imaging Modality: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI-enabled Imaging Modality Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Computed Tomography
1.2.3 MRI
1.2.4 X-Ray
1.2.5 Ultrasound
1.2.6 Positron Emission Tomography
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global AI-enabled Imaging Modality Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Cilinic
1.3.4 Labs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI-enabled Imaging Modality Revenue Estimates and Forecasts 2020-2031
2.2 Global AI-enabled Imaging Modality Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI-enabled Imaging Modality Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI-enabled Imaging Modality Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Computed Tomography Market Size by Players
3.3.2 MRI Market Size by Players
3.3.3 X-Ray Market Size by Players
3.3.4 Ultrasound Market Size by Players
3.3.5 Positron Emission Tomography Market Size by Players
3.3.6 Others Market Size by Players
3.4 Global AI-enabled Imaging Modality Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI-enabled Imaging Modality Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI-enabled Imaging Modality Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI-enabled Imaging Modality Market Size by Type (2020-2031)
6.4 North America AI-enabled Imaging Modality Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI-enabled Imaging Modality Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI-enabled Imaging Modality Market Size by Type (2020-2031)
7.4 Europe AI-enabled Imaging Modality Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI-enabled Imaging Modality Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI-enabled Imaging Modality Market Size by Type (2020-2031)
8.4 Asia-Pacific AI-enabled Imaging Modality Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI-enabled Imaging Modality Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI-enabled Imaging Modality Market Size by Type (2020-2031)
9.4 Central and South America AI-enabled Imaging Modality Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI-enabled Imaging Modality Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI-enabled Imaging Modality Market Size by Type (2020-2031)
10.4 Middle East and Africa AI-enabled Imaging Modality Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI-enabled Imaging Modality Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Koninklijke Philips N.V.
11.1.1 Koninklijke Philips N.V. Corporation Information
11.1.2 Koninklijke Philips N.V. Business Overview
11.1.3 Koninklijke Philips N.V. AI-enabled Imaging Modality Product Features and Attributes
11.1.4 Koninklijke Philips N.V. AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.1.5 Koninklijke Philips N.V. AI-enabled Imaging Modality Revenue by Product in 2024
11.1.6 Koninklijke Philips N.V. AI-enabled Imaging Modality Revenue by Application in 2024
11.1.7 Koninklijke Philips N.V. AI-enabled Imaging Modality Revenue by Geographic Area in 2024
11.1.8 Koninklijke Philips N.V. AI-enabled Imaging Modality SWOT Analysis
11.1.9 Koninklijke Philips N.V. Recent Developments
11.2 Siemens Healthineers AG.
11.2.1 Siemens Healthineers AG. Corporation Information
11.2.2 Siemens Healthineers AG. Business Overview
11.2.3 Siemens Healthineers AG. AI-enabled Imaging Modality Product Features and Attributes
11.2.4 Siemens Healthineers AG. AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.2.5 Siemens Healthineers AG. AI-enabled Imaging Modality Revenue by Product in 2024
11.2.6 Siemens Healthineers AG. AI-enabled Imaging Modality Revenue by Application in 2024
11.2.7 Siemens Healthineers AG. AI-enabled Imaging Modality Revenue by Geographic Area in 2024
11.2.8 Siemens Healthineers AG. AI-enabled Imaging Modality SWOT Analysis
11.2.9 Siemens Healthineers AG. Recent Developments
11.3 General Electric Company
11.3.1 General Electric Company Corporation Information
11.3.2 General Electric Company Business Overview
11.3.3 General Electric Company AI-enabled Imaging Modality Product Features and Attributes
11.3.4 General Electric Company AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.3.5 General Electric Company AI-enabled Imaging Modality Revenue by Product in 2024
11.3.6 General Electric Company AI-enabled Imaging Modality Revenue by Application in 2024
11.3.7 General Electric Company AI-enabled Imaging Modality Revenue by Geographic Area in 2024
11.3.8 General Electric Company AI-enabled Imaging Modality SWOT Analysis
11.3.9 General Electric Company Recent Developments
11.4 Canon
11.4.1 Canon Corporation Information
11.4.2 Canon Business Overview
11.4.3 Canon AI-enabled Imaging Modality Product Features and Attributes
11.4.4 Canon AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.4.5 Canon AI-enabled Imaging Modality Revenue by Product in 2024
11.4.6 Canon AI-enabled Imaging Modality Revenue by Application in 2024
11.4.7 Canon AI-enabled Imaging Modality Revenue by Geographic Area in 2024
11.4.8 Canon AI-enabled Imaging Modality SWOT Analysis
11.4.9 Canon Recent Developments
11.5 Hologic
11.5.1 Hologic Corporation Information
11.5.2 Hologic Business Overview
11.5.3 Hologic AI-enabled Imaging Modality Product Features and Attributes
11.5.4 Hologic AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.5.5 Hologic AI-enabled Imaging Modality Revenue by Product in 2024
11.5.6 Hologic AI-enabled Imaging Modality Revenue by Application in 2024
11.5.7 Hologic AI-enabled Imaging Modality Revenue by Geographic Area in 2024
11.5.8 Hologic AI-enabled Imaging Modality SWOT Analysis
11.5.9 Hologic Recent Developments
11.6 Butterfly Network
11.6.1 Butterfly Network Corporation Information
11.6.2 Butterfly Network Business Overview
11.6.3 Butterfly Network AI-enabled Imaging Modality Product Features and Attributes
11.6.4 Butterfly Network AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.6.5 Butterfly Network Recent Developments
11.7 Hyperfine
11.7.1 Hyperfine Corporation Information
11.7.2 Hyperfine Business Overview
11.7.3 Hyperfine AI-enabled Imaging Modality Product Features and Attributes
11.7.4 Hyperfine AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.7.5 Hyperfine Recent Developments
11.8 United Health Imaging
11.8.1 United Health Imaging Corporation Information
11.8.2 United Health Imaging Business Overview
11.8.3 United Health Imaging AI-enabled Imaging Modality Product Features and Attributes
11.8.4 United Health Imaging AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.8.5 United Health Imaging Recent Developments
11.9 Yorlabs
11.9.1 Yorlabs Corporation Information
11.9.2 Yorlabs Business Overview
11.9.3 Yorlabs AI-enabled Imaging Modality Product Features and Attributes
11.9.4 Yorlabs AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.9.5 Yorlabs Recent Developments
11.10 Nanox
11.10.1 Nanox Corporation Information
11.10.2 Nanox Business Overview
11.10.3 Nanox AI-enabled Imaging Modality Product Features and Attributes
11.10.4 Nanox AI-enabled Imaging Modality Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 AI-enabled Imaging ModalityIndustry Chain Analysis
12.1 AI-enabled Imaging Modality Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI-enabled Imaging Modality Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI-enabled Imaging Modality Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global AI-enabled Imaging Modality Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI-enabled Imaging Modality Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI-enabled Imaging Modality Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI-enabled Imaging Modality Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI-enabled Imaging Modality Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI-enabled Imaging Modality Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI-enabled Imaging Modality Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI-enabled Imaging Modality by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-enabled Imaging Modality as of 2024)
Table 11. Global AI-enabled Imaging Modality Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI-enabled Imaging Modality Companies Headquarters
Table 13. Global AI-enabled Imaging Modality Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI-enabled Imaging Modality Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI-enabled Imaging Modality Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI-enabled Imaging Modality Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI-enabled Imaging Modality Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI-enabled Imaging Modality High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI-enabled Imaging Modality Growth Accelerators and Market Barriers
Table 25. North America AI-enabled Imaging Modality Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI-enabled Imaging Modality Growth Accelerators and Market Barriers
Table 27. Europe AI-enabled Imaging Modality Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI-enabled Imaging Modality Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI-enabled Imaging Modality Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI-enabled Imaging Modality Investment Opportunities and Key Challenges
Table 31. Central and South America AI-enabled Imaging Modality Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI-enabled Imaging Modality Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI-enabled Imaging Modality Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Koninklijke Philips N.V. Corporation Information
Table 35. Koninklijke Philips N.V. Description and Major Businesses
Table 36. Koninklijke Philips N.V. Product Features and Attributes
Table 37. Koninklijke Philips N.V. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Koninklijke Philips N.V. Revenue Proportion by Product in 2024
Table 39. Koninklijke Philips N.V. Revenue Proportion by Application in 2024
Table 40. Koninklijke Philips N.V. Revenue Proportion by Geographic Area in 2024
Table 41. Koninklijke Philips N.V. AI-enabled Imaging Modality SWOT Analysis
Table 42. Koninklijke Philips N.V. Recent Developments
Table 43. Siemens Healthineers AG. Corporation Information
Table 44. Siemens Healthineers AG. Description and Major Businesses
Table 45. Siemens Healthineers AG. Product Features and Attributes
Table 46. Siemens Healthineers AG. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Siemens Healthineers AG. Revenue Proportion by Product in 2024
Table 48. Siemens Healthineers AG. Revenue Proportion by Application in 2024
Table 49. Siemens Healthineers AG. Revenue Proportion by Geographic Area in 2024
Table 50. Siemens Healthineers AG. AI-enabled Imaging Modality SWOT Analysis
Table 51. Siemens Healthineers AG. Recent Developments
Table 52. General Electric Company Corporation Information
Table 53. General Electric Company Description and Major Businesses
Table 54. General Electric Company Product Features and Attributes
Table 55. General Electric Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. General Electric Company Revenue Proportion by Product in 2024
Table 57. General Electric Company Revenue Proportion by Application in 2024
Table 58. General Electric Company Revenue Proportion by Geographic Area in 2024
Table 59. General Electric Company AI-enabled Imaging Modality SWOT Analysis
Table 60. General Electric Company Recent Developments
Table 61. Canon Corporation Information
Table 62. Canon Description and Major Businesses
Table 63. Canon Product Features and Attributes
Table 64. Canon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Canon Revenue Proportion by Product in 2024
Table 66. Canon Revenue Proportion by Application in 2024
Table 67. Canon Revenue Proportion by Geographic Area in 2024
Table 68. Canon AI-enabled Imaging Modality SWOT Analysis
Table 69. Canon Recent Developments
Table 70. Hologic Corporation Information
Table 71. Hologic Description and Major Businesses
Table 72. Hologic Product Features and Attributes
Table 73. Hologic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Hologic Revenue Proportion by Product in 2024
Table 75. Hologic Revenue Proportion by Application in 2024
Table 76. Hologic Revenue Proportion by Geographic Area in 2024
Table 77. Hologic AI-enabled Imaging Modality SWOT Analysis
Table 78. Hologic Recent Developments
Table 79. Butterfly Network Corporation Information
Table 80. Butterfly Network Description and Major Businesses
Table 81. Butterfly Network Product Features and Attributes
Table 82. Butterfly Network Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Butterfly Network Recent Developments
Table 84. Hyperfine Corporation Information
Table 85. Hyperfine Description and Major Businesses
Table 86. Hyperfine Product Features and Attributes
Table 87. Hyperfine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Hyperfine Recent Developments
Table 89. United Health Imaging Corporation Information
Table 90. United Health Imaging Description and Major Businesses
Table 91. United Health Imaging Product Features and Attributes
Table 92. United Health Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. United Health Imaging Recent Developments
Table 94. Yorlabs Corporation Information
Table 95. Yorlabs Description and Major Businesses
Table 96. Yorlabs Product Features and Attributes
Table 97. Yorlabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Yorlabs Recent Developments
Table 99. Nanox Corporation Information
Table 100. Nanox Description and Major Businesses
Table 101. Nanox Product Features and Attributes
Table 102. Nanox Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Nanox Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. AI-enabled Imaging Modality Product Picture
Figure 2. Global AI-enabled Imaging Modality Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Computed Tomography Product Picture
Figure 4. MRI Product Picture
Figure 5. X-Ray Product Picture
Figure 6. Ultrasound Product Picture
Figure 7. Positron Emission Tomography Product Picture
Figure 8. Others Product Picture
Figure 9. Global AI-enabled Imaging Modality Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Hospital
Figure 11. Cilinic
Figure 12. Labs
Figure 13. AI-enabled Imaging Modality Report Years Considered
Figure 14. Global AI-enabled Imaging Modality Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 16. Global AI-enabled Imaging Modality Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global AI-enabled Imaging Modality Revenue Market Share by Region (2020-2031)
Figure 18. Global AI-enabled Imaging Modality Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Computed Tomography Revenue Market Share by Player in 2024
Figure 21. MRI Revenue Market Share by Player in 2024
Figure 22. X-Ray Revenue Market Share by Player in 2024
Figure 23. Ultrasound Revenue Market Share by Player in 2024
Figure 24. Positron Emission Tomography Revenue Market Share by Player in 2024
Figure 25. Others Revenue Market Share by Player in 2024
Figure 26. Global AI-enabled Imaging Modality Revenue Market Share by Type (2020-2031)
Figure 27. Global AI-enabled Imaging Modality Revenue Market Share by Application (2020-2031)
Figure 28. North America AI-enabled Imaging Modality Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Players AI-enabled Imaging Modality Revenue (US$ Million) in 2024
Figure 30. North America AI-enabled Imaging Modality Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America AI-enabled Imaging Modality Revenue (US$ Million) by Application (2020-2031)
Figure 32. US AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 33. Canada AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 35. Europe AI-enabled Imaging Modality Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Europe Top 5 Players AI-enabled Imaging Modality Revenue (US$ Million) in 2024
Figure 37. Europe AI-enabled Imaging Modality Revenue (US$ Million) by Type (2020-2031)
Figure 38. Europe AI-enabled Imaging Modality Revenue (US$ Million) by Application (2020-2031)
Figure 39. Germany AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 40. France AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 41. U.K. AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 42. Italy AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 43. Russia AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific AI-enabled Imaging Modality Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Top 8 Players AI-enabled Imaging Modality Revenue (US$ Million) in 2024
Figure 46. Asia-Pacific AI-enabled Imaging Modality Revenue (US$ Million) by Type (2020-2031)
Figure 47. Asia-Pacific AI-enabled Imaging Modality Revenue (US$ Million) by Application (2020-2031)
Figure 48. Indonesia AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 49. Japan AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 50. South Korea AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 51. Australia AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 52. India AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 53. Indonesia AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 54. Vietnam AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 55. Malaysia AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 56. Philippines AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 57. Singapore AI-enabled Imaging Modality Revenue (2020-2031) & (US$ Million)
Figure 58. Central and South America AI-enabled Imaging Modality Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Central and South America Top 5 Players AI-enabled Imaging Modality Revenue (US$ Million) in 2024
Figure 60. Central and South America AI-enabled Imaging Modality Revenue (US$ Million) by Type (2020-2031)
Figure 61. Central and South America AI-enabled Imaging Modality Revenue (US$ Million) by Application (2020-2031)
Figure 62. Brazil AI-enabled Imaging Modality Revenue (2020-2025) & (US$ Million)
Figure 63. Argentina AI-enabled Imaging Modality Revenue (2020-2025) & (US$ Million)
Figure 64. Middle East and Africa AI-enabled Imaging Modality Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Middle East and Africa Top 5 Players AI-enabled Imaging Modality Revenue (US$ Million) in 2024
Figure 66. South America AI-enabled Imaging Modality Revenue (US$ Million) by Type (2020-2031)
Figure 67. Middle East and Africa AI-enabled Imaging Modality Revenue (US$ Million) by Application (2020-2031)
Figure 68. GCC Countries AI-enabled Imaging Modality Revenue (2020-2025) & (US$ Million)
Figure 69. Israel AI-enabled Imaging Modality Revenue (2020-2025) & (US$ Million)
Figure 70. Egypt AI-enabled Imaging Modality Revenue (2020-2025) & (US$ Million)
Figure 71. South Africa AI-enabled Imaging Modality Revenue (2020-2025) & (US$ Million)
Figure 72. AI-enabled Imaging Modality Industry Chain Mapping
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global AI-enabled Imaging Modality market?
The top companies in the global AI-enabled Imaging Modality market are Koninklijke Philips N.V.、Siemens Healthineers AG.、General Electric Company.
Related Reports
AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 108
USD 3950.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2026
The global AI-enabled Imaging Modality market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 104
USD 2900.00
(Single User License)
Global AI-enabled Imaging Modality Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-enabled Imaging Modality market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 78
USD 4250.00
(Single User License)
AI-enabled Imaging Modality- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 81
USD 3950.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2025
The global market for AI-enabled Imaging Modality was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 77
USD 2900.00
(Single User License)
Global AI-enabled Imaging Modality Market Insights, Forecast to 2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-04-26
Pages: 112
USD 4900.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2024
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-02-06
Pages: 87
USD 2900.00
(Single User License)
AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-01-12
Pages: 112
USD 3950.00
(Single User License)
AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 108
USD 3950.00 (Single User License)Global AI-enabled Imaging Modality Market Research Report 2026
The global AI-enabled Imaging Modality market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 104
USD 2900.00 (Single User License)Global AI-enabled Imaging Modality Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-enabled Imaging Modality market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 78
USD 4250.00 (Single User License)AI-enabled Imaging Modality- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 81
USD 3950.00 (Single User License)Global AI-enabled Imaging Modality Market Research Report 2025
The global market for AI-enabled Imaging Modality was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 77
USD 2900.00 (Single User License)Global AI-enabled Imaging Modality Market Insights, Forecast to 2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-04-26
Pages: 112
USD 4900.00 (Single User License)Global AI-enabled Imaging Modality Market Research Report 2024
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-02-06
Pages: 87
USD 2900.00 (Single User License)AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-01-12
Pages: 112
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now